CDK12 and cancer: Our results show that CDK12‐regulated RNAPII processivity of core DNA replication genes is a key rate‐limiting step of DNA replication and cell cycle progression and shed light into the mechanism of genomic instability associated with frequent aberrations of CDK12 kinase activity reported in many cancers.